Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.5750
-0.0710
(-10.99%)
At close: April 4 at 8:02:13 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-23,444
-23,444
-32,995
-7,731
-64,347
Investing Cash Flow
10,532
--
--
33,807
7,672
Financing Cash Flow
--
--
221
-29,553
84,050
End Cash Position
52,889
52,889
76,333
109,107
112,584
Income Tax Paid Supplemental Data
99
99
2,212
--
--
Issuance of Capital Stock
--
--
221
24,512
35,368
Free Cash Flow
-23,444
-23,444
-32,995
-7,731
-64,347
12/31/2021 - 10/13/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ZH6.BE Biohaven Ltd. R
17.10
-8.56%
HQ1.MU Oruka Therapeutics Inc. R
8.25
-6.25%
5KW.F SkinBioTherapeutics plc
0.2620
-6.43%
HPHA.F Heidelberg Pharma AG
2.6500
-6.03%
22Z.SG Zealand Pharma A/S
58.30
-6.65%
NP5.F Newron Pharmaceuticals S.p.A.
6.32
-10.99%
05Y.F Vivoryon Therapeutics N.V.
1.7460
+0.92%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.3040
-1.62%
NKB2.F TG Therapeutics, Inc.
35.07
-1.21%
ASCLF Ascletis Pharma Inc.
1.2000
0.00%